Lineage Cell Therapeutics (LCTX) Interest & Investment Income (2019 - 2021)
Lineage Cell Therapeutics' Interest & Investment Income came in at $2,000 for Q1 2021, down 99.5% from $405,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Interest & Investment Income (2019 - 2021) Analysis & Trends
Over the trailing twelve months to Mar 31, 2021, Lineage Cell Therapeutics reported Interest & Investment Income of $636,000, down 61.4% year-over-year; for FY2020, it was $1.04 million, down 38.3% from FY2019.
- Going back by year, Interest & Investment Income was $1.69 million in FY2019.
- The five-year range for quarterly Interest & Investment Income is $2,000 (Q4 2020) to $442,000 (Q1 2019).
- Year-over-year, Interest & Investment Income has declined for five consecutive quarters, with an average decline of 51.5% over the last five quarters.
- Business Quant data shows LCTX's Interest & Investment Income at $2,000 (Q4 2020), $252,000 (Q3 2020) and $380,000 (Q2 2020) in the three quarters before Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Sep 30, 2020 | 252,000.00 |
| Jun 30, 2020 | 380,000.00 |
| Mar 31, 2020 | 405,000.00 |
| Dec 31, 2019 | 407,000.00 |
| Sep 30, 2019 | 399,000.00 |
| Jun 30, 2019 | 437,000.00 |
| Mar 31, 2019 | 442,000.00 |
API Access
Lineage Cell Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();